NCT00743444View on ClinicalTrials.gov

TLESR-impedance Study in Patients

PHASE2CompletedINTERVENTIONAL

Enrollment

27

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

February 29, 2008

Study Completion Date

February 29, 2008

Conditions

Reflux Episodes

Interventions

DRUG

AZD3355

65 mg capsules, oral, 3 single doses

DRUG

Placebo

capsules, oral, 3 single doses

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY

NCT00743444 - TLESR-impedance Study in Patients | Biotech Hunter | Biotech Hunter